Clinical Trial Update: Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the clinical benefit of lenalidomide in combination with dexamethasone for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Kosin University Gospel Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN